Industry News

Central Ohio Urology Group is excited to announce the passage of H.R. 6092, the Veteran’s Prostate Cancer Treatment and Research Act. This important piece of bipartisan legislation was introduced [...]

Designation Recognized Dr. Cunningham’s Commitment to Exemplary Care, Extensive UroLift® System Experience NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on [...]

Newer treatments, such as immunotherapy, work best when administered before advanced prostate cancer has spread to vital organs. For Dr. Ben Martin, an advanced prostate cancer specialist at [...]

Men with prostate cancer often survive 15 years or longer after learning they have the disease, but prostate cancer remains one of the five most common cancers and the second most frequent cause [...]

Columbus Monthly magazine features physicians at Central Ohio Urology Group that are among few in the nation to provide HIFU for prostate cancer which is really changing the way men with [...]